Can Metabolic Factors be used Prognostically for Short-Term Mortality in HIV-Infected Patients?

Metabolic abnormalities are common throughout the course of human immunodeficiency virus (HIV) infection and may occur either due to HIV infection or as a result of side effects of antiretroviral therapy. It has been established that dyslipidemia and dysglycemia associated with HIV disease reduce th...

Full description

Saved in:
Bibliographic Details
Published in:Annals of medical and health sciences research 2012-07, Vol.2 (2), p.124-128
Main Authors: Jain, N, Tripathi, Ak, Vaish, Ak, Verma, Sp, Himanshu, D, Gutch, M
Format: Article
Language:English
Subjects:
Demographic aspects
Diagnosis
HIV infection
Metabolic diseases
Original
Outcome and process assessment (Health Care)
Prognosis
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Metabolic abnormalities are common throughout the course of human immunodeficiency virus (HIV) infection and may occur either due to HIV infection or as a result of side effects of antiretroviral therapy. It has been established that dyslipidemia and dysglycemia associated with HIV disease reduce the long-term survival of the patients, but their role for predicting prognosis of short-term mortality in HIV patients is unknown. To study dyslipidemia and dysglycemia as a prognostic indicator for short-term mortality (
ISSN:2141-9248
2277-9205
DOI:10.4103/2141-9248.105658